Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Orbcomm Inc. (ORBC): Raging Capital Management Decreases Stake

Page 1 of 6

William Martin‘s Raging Capital Management reported lowering its stake in Orbcomm Inc. (NASDAQ:ORBC) through an amended 13G filing with the US Securities and Exchange Commission. Now, the fund’s stake consists of 4.75 million shares, which amass 6.7% of the company’s outstanding stock,  compared to 6.48 million shares Raging Capital Management held at the end of June, as reported in its last 13F filing.

Orbcomm is a company that provides Machine-to-Machine (M2M) communications solutions and Internet of Things (IoT) solutions, which encompass network connectivity, devices, and Web applications. Recently, the company has been awarded by the IoT Evolution magazine and IoT Evolution World, which acknowledged its two products, ORBCOMM PT 7000 and the ORBCOMMconnect multi-network management portal, as IoT Evolution Products of the Year. Over the past 12 months, the company’s stock has gained 66.21%. For the second quarter of 2016, Orbcomm disclosed a loss per share of $0.06, below the estimates of a loss per share of $0.02, and revenue of $50.06 million, topping the estimates of $49 million.

William Martin Raging Capital Management

Out of 749 hedge funds that we follow, 16 reported long positions in Orbcomm (NASDAQ:ORBC) at the end of June, down from 19 in the previous quarter. Some of the bullish investors encompassed John W. Rogers’s Ariel Investments with a position valued at $32.27 million, Phill Gross And Robert Atchinson’s Adage Capital Management, which held a position worth around $14.15 million in the stock, Chuck Royce’s Royce & Associates, Mike Masters’s Masters Capital Management, Charles Paquelet’s Skylands Capital, and Brandon Osten’s Venator Capital Management.

Some of the smart money managers who lost enthusiasm for Orbcomm (NASDAQ:ORBC) and sold off their positions during the quarter included Richard Driehaus’ Driehaus Capital, which dropped its position valued at the end of March at $1.95 million, Mark Broach’s Manatuck Hill Partners, which said goodbye to $1.27 million worth of Orbcomm’s shares, and Ken Griffin’s Citadel Investment Group.

Follow Orbcomm Inc. (NASDAQ:ORBC)
Trade (NASDAQ:ORBC) Now!

You can access the original SEC filing by clicking here.

William C. Martin
William C. Martin
Raging Capital Management

Page 1 of 6 – SEC Filing

Washington, D.C. 20549
(Rule 13d-102)


(Amendment No. 3)1
 (Name of Issuer)
Common Stock, $0.001 par value
 (Title of Class of Securities)
68555P 10 0
 (CUSIP Number)
August 31, 2016
 (Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   x  Rule 13d-1(b)
   o  Rule 13d-1(c)
   o  Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
      The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Orbcomm Inc. (NASDAQ:ORBC)
Trade (NASDAQ:ORBC) Now!
Page 1 of 6

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!